Hakutulokset - Ming‐Lung Yu

Tarkenna hakua
  1. 1
    Treatment of chronic hepatitis C in Asia: When East meets West

    Treatment of chronic hepatitis C in Asia: When East meets West Tekijä Ming‐Lung Yu, Wan‐Long Chuang

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy

    Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy Tekijä Chung‐Feng Huang, Ming‐Lung Yu

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Reply to the comment on “High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C”

    Reply to the comment on “High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C” Tekijä Yen‐Chun Chen, Ming‐Lung Yu

    Julkaistu 2025
    Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals

    Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals Tekijä Jacinta A. Holmes, Ming‐Lung Yu, Raymond T. Chung

    Julkaistu 2017
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment and antiviral therapy

    Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatmen... Tekijä Pei‐Chien Tsai, Chung‐Feng Huang, Ming‐Lung Yu

    Julkaistu 2016
    Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication

    Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication Tekijä Chung‐Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming‐Lung Yu

    Julkaistu 2024
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight

    MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight Tekijä Ziyan Pan, Maryam Al Khatry, Ming‐Lung Yu, Ashok Choudhury, Giada Sebastiani, Saleh A. Alqahtani, Mohammed Eslam

    Julkaistu 2024
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population

    IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population Tekijä Qiong Huang, Ji‐Ye Yin, Xingping Dai, Qi Pei, Min Dong, Zhiguang Zhou, Xi Huang, Ming‐Lung Yu, Hong‐Hao Zhou, Zhaoqian Liu

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis

    Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis Tekijä Jia‐Jung Lee, Ming‐Yen Lin, Jung‐San Chang, Chi‐Chih Hung, Jer‐Ming Chang, Hung‐Chun Chen, Ming‐Lung Yu, Shang‐Jyh Hwang

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development

    Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development Tekijä Hui Huang, Ming‐Lung Yu, Thomas E. Akie, Tyler B. Moran, Andrew J. Woo, Nathan Tu, Zachary Waldon, Yin Lin, Hanno Steen, Alan Cantor

    Julkaistu 2009
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Systematic review with meta‐analysis: extrahepatic manifestations in chronic hepatitis C virus‐infected patients in East Asia

    Systematic review with meta‐analysis: extrahepatic manifestations in chronic hepatitis C virus‐infected patients in East Asia Tekijä Zobair M. Younossi, Linda Henry, Janus P. Ong, Atsushi Tanaka, Yuichiro Eguchi, Masashi Mizokami, Young‐Suk Lim, Yock Young Dan, Ming‐Lung Yu, Maria Stepanova

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C

    Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C Tekijä Hsieh Mc, Ming‐Lung Yu, Wan‐Long Chuang, SJ Shin, CY Dai, Shuo Chen, Z-Y. Lin, MY Hsieh, JF Liu, Ling‐Yu Wang, Chang Wy

    Julkaistu 2000
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    The impact of hepatitis C virus outside the liver: Evidence from Asia

    The impact of hepatitis C virus outside the liver: Evidence from Asia Tekijä Zobair M. Younossi, Atsushi Tanaka, Yuichiro Eguchi, Young‐Suk Lim, Ming‐Lung Yu, Norifumi Kawada, Yock Young Dan, C. Brooks-Rooney, Francesco Negro, Mario U. Mondelli

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Viral Interaction and Responses in Chronic Hepatitis C and B Coinfected Patients with Interferon-Alpha plus Ribavirin Combination Therapy

    Viral Interaction and Responses in Chronic Hepatitis C and B Coinfected Patients with Interferon-Alpha plus Ribavirin Combination Therapy Tekijä Wan‐Long Chuang, Chia‐Yen Dai, Wen‐Yu Chang, Li‐Po Lee, Zu‐Yau Lin, Shinn‐Cherng Chen, Ming‐Yuh Hsieh, Liang‐Yen Wang, Ming‐Lung Yu

    Julkaistu 2005
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    The first case of monkeypox virus infection detected in Taiwan: awareness and preparation

    The first case of monkeypox virus infection detected in Taiwan: awareness and preparation Tekijä Zih‐Syuan Yang, C. C. Lin, Aspiro Nayim Urbina, Wen‐Hung Wang, Wanchai Assavalapsakul, Sung‐Pin Tseng, Po‐Liang Lu, Yen‐Hsu Chen, Ming‐Lung Yu, Sheng‐Fan Wang

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Significant correlations between severe fatty liver and risk factors for metabolic syndrome

    Significant correlations between severe fatty liver and risk factors for metabolic syndrome Tekijä Pi‐Jung Hsiao, Kung‐Kai Kuo, Shyi–Jang Shin, Yi‐Hsin Yang, Wen‐Yi Lin, Jeng‐Fu Yang, Chao‐Chin Chiu, Wan‐Long Chuang, Tong‐Rong Tsai, Ming‐Lung Yu

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Association of Dialysis with the Risks of Cancers

    Association of Dialysis with the Risks of Cancers Tekijä Ming‐Yen Lin, Mei Chuan Kuo, Chi-Chih Hung, Wen‐Jeng Wu, Li Tzong Chen, Ming‐Lung Yu, Chih‐Cheng Hsu, Chien‐Hung Lee, Hung‐Chun Chen, Shang‐Jyh Hwang

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Diagnostic Value of Immunoglobulin G (IgG) and IgM Anti-Hepatitis E Virus (HEV) Tests Based on HEV RNA in an Area Where Hepatitis E Is Not Endemic

    Diagnostic Value of Immunoglobulin G (IgG) and IgM Anti-Hepatitis E Virus (HEV) Tests Based on HEV RNA in an Area Where Hepatitis E Is Not Endemic Tekijä Chen‐Chun Lin, Jaw‐Ching Wu, Ting‐Tsung Chang, Wen‐Yu Chang, Ming‐Lung Yu, Albert W. Tam, Shen-Chin Wang, Yi‐Hsiang Huang, Full‐Young Chang, Shou‐Dong Lee

    Julkaistu 2000
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Study in Taiwan

    A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Stud... Tekijä Ming‐Lung Yu, Shi‐Ming Lin, Wan‐Long Chuang, Chia‐Yen Dai, Jing‐Houng Wang, Sheng‐Nan Lu, I‐Shyan Sheen, Wen‐Yu Chang, Chuan–Mo Lee, Yun–Fan Liaw

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection

    Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection Tekijä Chia‐Yen Dai, Ching‐Yeh Lin, Pei‐Chien Tsai, Ping‐Yi Lin, Ming‐Lun Yeh, Chung‐Feng Huang, Wen‐Tsan Chang, Jee‐Fu Huang, Ming‐Lung Yu, Yao‐Li Chen

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: